Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Shipman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
F1000Research|March 28, 2017
Tertiary lymphoid organs in systemic autoimmune diseases:  pathogenic or protective?William D Shipman, Dragos C Dasoveanu, Theresa T Lu
Journal of the American Academy of Dermatology|July 16, 2019
An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic reviewWilliam D Shipman, Nicholas A Vernice, Michelle Demetres, et al.
Current Opinion in Immunology|May 11, 2020
Fibroblast subtypes in tissues affected by autoimmunity: with lessons from lymph node fibroblastsWilliam D Shipman, Marvin J Sandoval, Keila Veiga, et al.
Trends in Immunology|September 18, 2016
Regulation of Lymph Node Vascular-Stromal Compartment by Dendritic CellsDragos C Dasoveanu, William D Shipman, Jennifer J Chia, et al.
The British Journal of Dermatology|November 10, 2023
Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy: reply from the authorsWilliam D Shipman, Katelyn Singh, Jeffery M Cohen, et al.
The British Journal of Dermatology|May 4, 2023
Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatmentWilliam D Shipman, Katelyn Singh, Jeffrey M Cohen, et al.
Lasers in Surgery and Medicine|May 21, 2024
Efficacy of laser hair removal in hidradenitis suppurativa: A systematic review and meta-analysisWilliam D Shipman, Monica N Williams, Kathleen C Suozzi, et al.
Clinical and Experimental Dermatology|November 22, 2024
The association of hidradenitis suppurativa with cigarette smoking and cannabis use: a cross-sectional study in the All of Us Research ProgramGloria F Chen, William D Shipman, Christine Hodelin, et al.
Frontiers in Immunology|April 6, 2019
Lymphatic Function in Autoimmune DiseasesNoa Schwartz, Madhavi Latha S Chalasani, Thomas M Li, et al.
Journal of the American Academy of Dermatology|May 12, 2020
Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativaJanyla A Seltzer, Chidubem A V Okeke, Jessica D Perry, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
F1000Research|March 28, 2017
Tertiary lymphoid organs in systemic autoimmune diseases:  pathogenic or protective?William D Shipman, Dragos C Dasoveanu, Theresa T Lu
Journal of the American Academy of Dermatology|July 16, 2019
An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic reviewWilliam D Shipman, Nicholas A Vernice, Michelle Demetres, et al.
Current Opinion in Immunology|May 11, 2020
Fibroblast subtypes in tissues affected by autoimmunity: with lessons from lymph node fibroblastsWilliam D Shipman, Marvin J Sandoval, Keila Veiga, et al.
Trends in Immunology|September 18, 2016
Regulation of Lymph Node Vascular-Stromal Compartment by Dendritic CellsDragos C Dasoveanu, William D Shipman, Jennifer J Chia, et al.
The British Journal of Dermatology|November 10, 2023
Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy: reply from the authorsWilliam D Shipman, Katelyn Singh, Jeffery M Cohen, et al.
The British Journal of Dermatology|May 4, 2023
Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatmentWilliam D Shipman, Katelyn Singh, Jeffrey M Cohen, et al.
Lasers in Surgery and Medicine|May 21, 2024
Efficacy of laser hair removal in hidradenitis suppurativa: A systematic review and meta-analysisWilliam D Shipman, Monica N Williams, Kathleen C Suozzi, et al.
Clinical and Experimental Dermatology|November 22, 2024
The association of hidradenitis suppurativa with cigarette smoking and cannabis use: a cross-sectional study in the All of Us Research ProgramGloria F Chen, William D Shipman, Christine Hodelin, et al.
Frontiers in Immunology|April 6, 2019
Lymphatic Function in Autoimmune DiseasesNoa Schwartz, Madhavi Latha S Chalasani, Thomas M Li, et al.
Journal of the American Academy of Dermatology|May 12, 2020
Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativaJanyla A Seltzer, Chidubem A V Okeke, Jessica D Perry, et al.
Pageof 3